FDA Signals Are Breaking Biotech | Collapse, Breakthrough, and What Congress Does Next
FDA signals are starting to break down, and biotech is feeling it. One company is collapsing while another is breaking through.
As lawmakers return to Washington for a packed schedule of healthcare hearings, the conversation will be shaped by what’s happening inside the biotech ecosystem right now, both the breakthroughs and the breakdowns.
In this episode of Making Medicine, we connect the dots between what’s unfolding on Capitol Hill and what companies are experiencing on the ground.
We start with the policy backdrop: multiple hearings across the House and Senate, including appearances by…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.